How Many Cocrystals Are We Missing? Assessing Two Crystal Engineering Approaches to Pharmaceutical Cocrystal Screening

Chiara Cappuccino,David Cusack,James Flanagan,Carl Harrison,Cillian Holohan,Monica Lestari,Gareth Walsh,Matteo Lusi
DOI: https://doi.org/10.1021/acs.cgd.1c01342
2022-01-10
Abstract:Drug development may include extensive screening for crystalline forms of active pharmaceutical ingredients. Crystal engineering aims to apply supramolecular knowledge to simplify such a task. The failure of such a strategy may result in overlooking potentially interesting compounds. Here, the advantages of such a knowledge-based approach is compared to a systematic crystallization screening for pharmaceutical cocrystals. This work indicates that a screening simply based on known synthons and their relative frequency as reported in the database is as effective as a random screening exercise, potentially missing 25% of the successful cocrystallization. Readily available computational methods perform better, enabling the identification of all of the observed cocrystals with a reduction of 24% of the experimental attempts.
chemistry, multidisciplinary,materials science,crystallography
What problem does this paper attempt to address?